Swiss National Bank Myriad Genetics Inc Transaction History

Swiss National Bank

$146 Billion
Q4 2024

A detailed history of Swiss National Bank transactions in Myriad Genetics Inc stock. As of the latest transaction made, Swiss National Bank holds 178,600 shares of MYGN stock, worth $2.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

178,600

Previous 176,800 1.02%

Holding current value

$2.06 Million

Previous $4.84 Million 49.41%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$13.17 - $27.03 $23,706 - $48,654	1,800 Added 1.02%	178,600 $2.45 Million
Q2 2024 Aug 08, 2024	BUY	$17.98 - $25.47 $37,758 - $53,487	2,100 Added 1.2%	176,800 $4.32 Million
Q1 2024 May 07, 2024	BUY	$17.59 - $23.59 $233,947 - $313,747	13,300 Added 8.24%	174,700 $3.72 Million
Q4 2023 Feb 06, 2024	SELL	$13.91 - $21.32 $248,989 - $381,628	-17,900 Reduced 9.98%	161,400 $3.09 Million
Q3 2023 Nov 08, 2023	BUY	$15.99 - $23.22 $28,782 - $41,796	1,800 Added 1.01%	179,300 $2.88 Million
Q2 2023 Aug 09, 2023	BUY	$17.56 - $23.76 $45,656 - $61,776	2,600 Added 1.49%	177,500 $4.11 Million
Q1 2023 May 10, 2023	SELL	$15.26 - $23.75 $302,148 - $470,250	-19,800 Reduced 10.17%	174,900 $4.06 Million
Q4 2022 Feb 08, 2023	BUY	$14.51 - $20.99 $60,942 - $88,158	4,200 Added 2.2%	194,700 $2.83 Million
Q3 2022 Nov 09, 2022	BUY	$18.21 - $27.88 $30,957 - $47,396	1,700 Added 0.9%	190,500 $3.64 Million
Q1 2022 May 09, 2022	BUY	$22.67 - $28.01 $387,657 - $478,971	17,100 Added 9.96%	188,800 $4.76 Million
Q4 2021 Feb 08, 2022	BUY	$24.13 - $32.63 $36,195 - $48,945	1,500 Added 0.88%	171,700 $4.74 Million
Q3 2021 Nov 08, 2021	BUY	$29.97 - $36.66 $131,868 - $161,303	4,400 Added 2.65%	170,200 $5.5 Million
Q2 2021 Aug 06, 2021	SELL	$25.39 - $32.61 $152,340 - $195,660	-6,000 Reduced 3.49%	165,800 $5.07 Million
Q1 2021 May 07, 2021	BUY	$19.92 - $31.6 $55,776 - $88,480	2,800 Added 1.66%	171,800 $5.23 Million
Q3 2020 Nov 09, 2020	BUY	$11.25 - $14.75 $29,250 - $38,350	2,600 Added 1.56%	169,000 $2.2 Million
Q2 2020 Aug 05, 2020	BUY	$10.69 - $16.49 $236,249 - $364,428	22,100 Added 15.32%	166,400 $1.89 Million
Q1 2020 May 08, 2020	BUY	$9.78 - $29.53 $28,361 - $85,637	2,900 Added 2.05%	144,300 $2.07 Million
Q4 2019 Feb 06, 2020	BUY	$20.93 - $35.1 $75,348 - $126,360	3,600 Added 2.61%	141,400 $3.85 Million
Q3 2019 Nov 12, 2019	BUY	$22.08 - $47.08 $33,120 - $70,620	1,500 Added 1.1%	137,800 $3.95 Million
Q1 2019 May 10, 2019	BUY	$26.93 - $34.7 $293,537 - $378,230	10,900 Added 8.69%	136,300 $4.53 Million
Q4 2018 Feb 13, 2019	BUY	$27.23 - $45.56 $103,474 - $173,128	3,800 Added 3.13%	125,400 $3.65 Million
Q2 2018 Aug 09, 2018	BUY	$27.75 - $40.17 $86,025 - $124,527	3,100 Added 2.62%	121,600 $4.54 Million
Q4 2017 Feb 07, 2018	BUY	$28.45 - $37.14 $110,955 - $144,846	3,900 Added 3.4%	118,500 $4.07 Million
Q3 2017 Nov 03, 2017	BUY	$24.01 - $36.2 $2.75 Million - $4.15 Million	114,600	114,600 $4.15 Million

Others Institutions Holding MYGN

# of Institutions

227

Shares Held

92M

Call Options Held

297K

Put Options Held

20.7K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $932M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Myriad Genetics Inc Transaction History